Patheon Pharmaceutica

AMAG Pharmaceuticals is a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. The company has two commercial products, Feridex I.V. and GastroMARK, both of which are imaging agents that are approved and marketed in the United States, Europe and other countries. Ferumoxytol, the company's key product candidate, is being developed for use as an intravenous iron replacement therapeutic for the treatment of iron deficiency anemia in chronic kidney disease. Combidex, the company's other product under development, is an investigational functional molecular imaging agent consisting of iron oxide nanoparticles for use in conjunction with magnetic resonance imaging (MRI) to aid in the differentiation of cancerous from normal lymph nodes. AMAG Pharmaceuticals corporate and executive offices are located in Cambridge, Mass.

Rxi Pharmaceuticals C is a biopharmaceutical company based in Marlborough, MA, specializing in the development of innovative medical treatments. With a focus on research and development, the company aims to address unmet medical needs and improve patient outcomes through cutting-edge therapies. Generated from their business information

Adnexus, a Bristol-Myers Squibb R&D company, is situated at 100 Beaver St in Waltham, Massachusetts, within Middlesex County. The company specializes in providing pharmaceutical containers and equipment supplies, catering to the needs of the medical field. Dedicated to enhancing pharmaceutical operations, Adnexus strives to ensure quality and efficiency in their products and services. Clients can share their experiences and reviews to aid others in finding valuable resources within the pharmaceutical industry. Generated from the website